Skip to main content

Clinical Trials Using Paclitaxel

Review the clinical trials studying paclitaxel on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 126-150 of 196

Carboplatin, Paclitaxel, and Pembrolizumab Before Surgery Followed by Olaparib and Pembrolizumab with or without Bevacizumab for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Propranolol and Chemoradiation Therapy for the Treatment of Patients with Esophageal Cancer
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Chemotherapy and Cemiplimab with or without Alirocumab before Surgery for the Treatment of Lung Cancer in Patients with Stage IB-IIIA Non-small Cell Lung Cancer
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
Circulating Tumor DNA Monitoring for Treatment Response Prediction and Treatment Reduction after Surgery in Patients with Stage IB, II, and IIIB Non-small Cell Lung Cancer, DNA-PREDICT Trial
Status: Active
Location: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
High Dose Radiation Therapy with Pembrolizumab and Chemotherapy for the Treatment of Patients with PD-L1 Positive Metastatic Triple Negative Breast Cancer
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
Darolutamide Alone or in Combination with Standard Therapy before Surgery for the Treatment of Stage II-IIIA, Androgen Receptor Positive, Triple-Negative Breast Carcinoma
Status: Active
Location: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
Carboplatin, Paclitaxel, and Ramucirumab for the Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Personalized Treatment with Surgery, Radiation and/or Chemotherapy for Patients with Stage I-II HPV-related Squamous Cell Carcinoma of the Oropharynx
Status: Active
Location: University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
Cemiplimab with or without Chemotherapy followed by Biomarker Guided De-escalated Therapy for the Treatment of Patients with HPV-related Oropharyngeal Squamous Cell Cancer, MINIMA Trial
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Involved Nodal Radiotherapy versus Elective Neck Radiotherapy for the Treatment of Stage I-IVB Oropharyngeal, Laryngeal, and Hypopharyngeal Squamous Cell Cancer, The INVERT Trial
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Pembrolizumab Plus Combination Chemotherapy before Surgery for the Treatment of Stage I Triple Negative Breast Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Reduced Dose Chemotherapy in Combination with Immunotherapy for the Treatment of Stage IV Non-small Cell Lung Cancer in Vulnerable or Older Adults with a PD-L1 Tumor Proportion Score < 50%
Status: Active
Location: VCU Massey Comprehensive Cancer Center, Richmond, Virginia
Immunotherapy versus Chemoimmunotherapy Guided by Circulating Tumor DNA-Based Molecular Response for the Treatment of Stage IV Non-small Cell Lung Cancer
Status: Active
Location: 2 locations
Response-Adaptive Chemoradiation after Induction Therapy for the Treatment of Patients with Locally Advanced Head and Neck Squamous Cell Cancer
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Dual Immune Strategy (Nivolumab and Ipilimumab) versus Single Checkpoint Blockade (Pembrolizumab) in Combination with Chemotherapy for the Treatment of PD-L1 Negative Stage IV Non-small Cell Lung Cancer, DISCERN Trial
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Evaluating Unilateral Radiation Therapy with and without Cisplatin in Treating Patients with HPV 16+ Oropharyngeal Cancer
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
Durvalumab in Combination with Chemotherapy in Treating Patients with Advanced Solid Tumors, DURVA+ Trial
Status: Active
Location: National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland
Intraperitoneal Paclitaxel for the Treatment of Patients with Metastatic Appendiceal Adenocarcinoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
RAPA-201 Therapy of Solid Tumors
Status: Active
Location: Hackensack University Medical Center, Hackensack, New Jersey
Epidiferphane and Taxane Chemotherapy for the Treatment of Breast Cancer
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida
Axatilimab in Combination with Retifanlimab and Paclitaxel for the Treatment of Patients with Advanced or Metastatic Solid Tumors
Status: Active
Location: OHSU Knight Cancer Institute, Portland, Oregon
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
External Beam Radiation Therapy and Brachytherapy with Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
Status: Active
Location: 5 locations